Search & Filter

California Governor Gavin Newsom signed a law requiring all California colleges and universities with student health centers to provide abortion pills by various means starting January 1, 2029, contingent on legislative funding. The law expands previous mandates and has raised concerns from pro-life groups about the lack of prenatal care and support for pregnant and parenting students on campuses.

Planned Parenthood Mar Monte, its largest affiliate, has started selling Botox and other beauty treatments at at least four California centers to address revenue shortfalls while continuing to provide abortions and other services. The affiliate reported budget difficulties leading to cutbacks in primary care and prenatal services, and its 2024-2025 annual report showed a record 434,450 abortions performed and $832 million in taxpayer funding received.

Louisiana Attorney General Liz Murrill announced federal lawsuits against New York, California, and Massachusetts for enabling mail-order abortions by refusing to extradite abortionists charged with sending abortion pills into Louisiana, where elective abortion is banned. The state argues that these 'shield' laws violate Louisiana's sovereignty and criminal laws, citing cases where mailed abortion drugs resulted in the deaths of babies and harm to women, and is also challenging the FDA's 2023 policy allowing telehealth prescribing and mail delivery of abortion pills in federal court.

The U.S. Supreme Court declined to intervene in the case of Alaska surrogate McKenna West, who refused to abort the baby she was carrying after he was diagnosed with a serious heart defect and sought a say in his care, leaving a California ruling recognizing the intended parents as the legal parents intact.

California is involved in a legal battle over abortion pill reversal (APR), a medical intervention that aims to counteract the effects of the abortion drug mifepristone by administering progesterone to sustain pregnancy. Organizations like Heartbeat International and Real Options face potential fines for offering APR, despite evidence from thousands of women who have successfully used the treatment to carry their pregnancies to term under medical supervision.